Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Prostate-specific antigen screening was highest among African American men and those concerned about prostate cancer and lowest when physicians did not discuss the test. Objective: To examine factors ...

As a retired clinical laboratorian, retired hospital laboratory manager, and prostate-cancer survivor, I feel I must respond to the articles “Fewer Men Diagnosed With Prostate Cancer” and “Restricting ...

Comprehensive genetic testing using multigene testing panels for prostate cancer can arm genetic counselors with the information they need to guide precision therapy, even in men with early stage ...

CINCINNATI (WKRC) - Defense Secretary Lloyd Austin’s diagnosis of prostate cancer has specialists reminding everyone about the importance of early detection. But, many men are still not getting the ...

Prostate cancer is a serious health concern that affects men of all races and backgrounds. However, research has shown that Black men are at a higher risk of developing prostate cancer and ...

Some patients with prostate cancer may want to consider genetic testing as it could provide a guideline for treatment and information for secondary cancer risk, while also allowing families to better ...

A 2-step decision analytic model consisting of a decision tree-informed Markov structure was used to estimate lifetime outcomes in older patients with prostate cancer. The P-score reclassifies a ...

Ever felt like you're just waiting for the other shoe to drop, especially regarding medical test results? Francis Collins, the former NIH director, found himself in that situation, dancing the ...

Metastatic castration-resistant prostate cancer (CRPC) is the lethal form of the disease. Many groups have performed mutational or immunohistochemistry (IHC) testing in metastatic CRPC to identify ...

Cases of advanced prostate cancer have increased among American men ages 50 and older, while cases of early-stage disease have declined, a study published Wednesday found. The study looked at cases ...